StabiLux receives funding for high-brightness fluorophore development

The funding will support commercialization of high-brightness fluorophores for use in multicolor flow cytometry.

StabiLux Biosciences, a company founded by Michigan Technological University (Houghton, MI) physics professor Yoke Khin Yap, has been awarded more than $650,000 to support commercialization of high-brightness fluorophores for use in multicolor flow cytometry for medical diagnostics and analysis.

Related: Cytometry method may aid discovery of rheumatoid arthritis therapies

The funding comes from America's Seed Fund, powered by the National Science Foundation (NSF) Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) program and the Invest Michigan's University Commercialization Fund (UCF), which provides funding to early-stage companies for the commercialization of technologies originating from Michigan's 15 public universities.

The company was awarded a $600,000 grant from NSF-STTR phase II to commercialize the technology by conducting research and development for biomedical applications. It will commercialize its high-brightness fluorophores under the registered trademark of NovoLux.

For more information, please visit

More in Biophotonics Techniques